A clean variety with potential to hit all soft markets.
LG Lotus
An exceptionally clean variety
- Status: National Listed
- Yield: Highest untreated yield in the group 3 sector
Strengths
-
Clean variety with potential to hit all soft markets
-
Short strawed variety
-
The only group 3 with a 7 rating for septoria
Technical Information
Yield (% of treated control)
| LG Lotus | |
|---|---|
| UK | 103 |
| East | 102 |
| West | 104 |
| North | (101) |
| UK Untreated Yield | 92 |
Disease Resistance
| LG Lotus | |
|---|---|
| Mildew | 5 |
| Yellow Rust | 7 |
| Brown Rust | 7 |
| Septoria Tritici | 7.1 |
| Eyespot | (3) |
| Fusarium Ear Blight | (6) |
| Orange Wheat Blossom Midge | R |
Grain Quality
| LG Lotus | |
|---|---|
| Endosperm Texture | Soft |
| Protein Content (%) | 10.6 |
| Hagberg Falling Number (seconds) | 246 |
| Specific Weight (kg/hl) | 76.8 |
| Resistance to Sprouting | (5) |
LG Lotus
An exceptionally clean variety
A clean variety with potential to hit all soft markets.

Ask an expert
- Or call us
- 01472 371661
Key Strengths
-
Clean variety with potential to hit all soft markets
-
Short strawed variety
-
The only group 3 with a 7 rating for septoria
Technical Information
Yield (% of treated control)
| LG Lotus | |
|---|---|
| UK | 103 |
| East | 102 |
| West | 104 |
| North | (101) |
| UK Untreated Yield | 92 |
Data taken from the AHDB RL Trials 2025. ( ) = limited data.
Disease Resistance
| LG Lotus | |
|---|---|
| Mildew | 5 |
| Yellow Rust | 7 |
| Brown Rust | 7 |
| Septoria Tritici | 7.1 |
| Eyespot | (3) |
| Fusarium Ear Blight | (6) |
| Orange Wheat Blossom Midge | R |
Data taken from the AHDB RL Trials 2025. See https://ahdb.org.uk/rl for full dataset. On the 1-9 scales, high figures indicate that the variety shows the character to a high degree (e.g. high resistance). ( ) = limited data.
Grain Quality
| LG Lotus | |
|---|---|
| Endosperm Texture | Soft |
| Protein Content (%) | 10.6 |
| Hagberg Falling Number (seconds) | 246 |
| Specific Weight (kg/hl) | 76.8 |
| Resistance to Sprouting | (5) |
Data taken from the AHDB RL Trials 2025. ( ) = limited data.